流感H5疫苗临床试验最新进展(2)

(参考文献7).WHO,  Nov.  2003,  Production  of  pilot  lots  of  inactivated  influenza  vaccines  reassortants  dereived  from  avian  influenza  viruses:  interim  biosafety  risk  assessment.

(参考文献8).EMEA,  April  2004,  Dossier  structure  and  content  for  pandemic  influenza  vaccine  marketing  authorization  application.

(参考文献9).John  J.  Treanor,  James  D.  Campbell,  Kenneth  M.  Zangwill,et  al.  Safety  and  Immunogenicity  of  an  Inactivated  Subvirion  Influenza  A（H5N1）Vaccine.  NEJM  354:1343-1351,  2006.

(参考文献10).Jean-Louis  Bresson,  Christian  Perronne,  Odile  Launay,  et  al.  Safety  and  immunogenicity  of  an  inactivated  split-virion  influenza  A/Vietnam/1194/2004（H5N1）vaccine:  phase  I  randomised  trial.  Lancet  367:  1657-1664,2006.

(参考文献11).The  World  Health  Organization  Global  Influenza  Program  Surveillance  Network.  Evolution  of  H5N1  Avian  Influenza  Viruses  in  Asia.  Emerg  Infect  Dis  2005;11:1515-21   (责任编辑：泉水)

搜索

热门标签:

流感H5疫苗临床试验最新进展(2)